Position
Squarepoint Ops LLC in Tyra Biosciences, Inc.
Back to the book · All holders of TYRA
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $246.1K$26.29 → $38.30
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 54.4K | $1.43M | — | — | — | 0.0% |
| Q1 2026 | 20.5K | $784.9K | $38.30 | $246.1K | −$892K | 0.0% |